Combinatorial control of transgene expression by hypoxia-responsive promoter and MicroRNA regulation for neural stem cell-based cancer therapy

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Luo, Yumei ^a   Zhu, Detu ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MICRORNA; MICRORNA 199A 5P; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER CELL LINE; BREAST TUMOR; CANCER THERAPY; CELL MIGRATION; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE VECTOR; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PLURIPOTENT STEM CELL; PROMOTER REGION; PROTEIN EXPRESSION; RNA SEQUENCE; TROPISM; ANIMAL; BAGG ALBINO MOUSE; CELL DIFFERENTIATION; CELL HYPOXIA; GENETICS; HEK293 CELL LINE; MCF 7 CELL LINE; METABOLISM; NEOPLASMS; NEURAL STEM CELL; PATHOLOGY; TRANSGENE;

ANIMALS; CELL DIFFERENTIATION; CELL HYPOXIA; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MCF-7 CELLS; MICE, INBRED BALB C; MICRORNAS; NEOPLASMS; NEURAL STEM CELLS; PROMOTER REGIONS, GENETIC; TRANSGENES;

EID: 84900016398     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/751397     Document Type: Article

References (30)

1. Zhu D., Lam D. H., Purwanti Y. I., Systemic delivery of fusogenic membrane glycoprotein-expressing neural stem cells to selectively kill tumor cells. Molecular Therapy 2013 21 8 1621 1630 10.1038/mt.2013.123
2. Li S., Tokuyama T., Yamamoto J., Koide M., Yokota N., Namba H., Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells. Cancer Gene Therapy 2005 12 7 600 607 2-s2.0-22044433684 10.1038/sj.cgt.7700826
3. Uhl M., Weiler M., Wick W., Jacobs A. H., Weller M., Herrlinger U., Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomas. Biochemical and Biophysical Research Communications 2005 328 1 125 129 2-s2.0-12844258193 10.1016/j.bbrc.2004.12.164
4. Benedetti S., Pirola B., Pollo B., Magrassi L., Bruzzone M. G., Rigamonti D., Galli R., Selleri S., di Meco F., de Fraja C., Vescovi A., Cattaneo E., Finocchiaro G., Gene therapy of experimental brain tumors using neural progenitor cells. Nature Medicine 2000 6 4 447 450 2-s2.0-0034117480 10.1038/74710
5. Yang J., Lam D. H., Goh S. S., Lee E. X., Zhao Y., Tay F. C., Chen C., Du S., Balasundaram G., Shahbazi M., Tham C. K., Ng W. H., Toh H. C., Wang S., Tumor tropism of intravenously injected human-induced pluripotent stem cell-derived neural stem cells and their gene therapy application in a metastatic breast cancer model. Stem Cells 2012 30 5 1021 1029 2-s2.0-84860519007 10.1002/stem.1051
6. Zhao D., Najbauer J., Annala A. J., Garcia E., Metz M. Z., Gutova M., Polewski M. D., Gilchrist M., Glackin C. A., Kim S. U., Aboody K. S., Human neural stem cell tropism to metastatic breast cancer. Stem Cells 2012 30 2 314 325 2-s2.0-84856082219 10.1002/stem.784
7. Zhao D., Najbauer J., Garcia E., Metz M. Z., Gutova M., Glackin C. A., Kim S. U., Aboody K. S., Neural stem cell tropism to glioma: critical role of tumor hypoxia. Molecular Cancer Research 2008 6 12 1819 1829 2-s2.0-57749089644 10.1158/1541-7786.MCR-08-0146
8. 2 availability on human cancer. Nature Reviews Cancer 2008 8 12 967 975 2-s2.0-57149142495 10.1038/nrc2540
9. Rankin E. B., Giaccia A. J., The role of hypoxia-inducible factors in tumorigenesis. Cell Death & Differentiation 2008 15 4 678 685 2-s2.0-40949142209 10.1038/cdd.2008.21
10. Heddleston J. M., Li Z., McLendon R. E., Hjelmeland A. B., Rich J. N., The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 2009 8 20 3274 3284 2-s2.0-70350225829
11. Keith B., Simon M. C., Hypoxia-inducible factors, stem cells, and cancer. Cell 2007 129 3 465 472 2-s2.0-34247527730 10.1016/j.cell.2007.04.019
12. Semenza G. L., Targeting HIF-1 for cancer therapy. Nature Reviews Cancer 2003 3 10 721 732 2-s2.0-0142166332
13. Camps C., Buffa F. M., Colella S., Moore J., Sotiriou C., Sheldon H., Harris A. L., Gleadle J. M., Ragoussis J., hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clinical Cancer Research 2008 14 5 1340 1348 2-s2.0-40949137731 10.1158/1078-0432.CCR-07-1755
14. Giannakakis A., Sandaltzopoulos R., Greshock J., Liang S., Huang J., Hasegawa K., Li C., O'Brien-Jenkins A., Katsaros D., Weber B. L., Simon C., Coukos G., Zhang L., miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biology & Therapy 2008 7 2 255 264 2-s2.0-42549092314
15. Rane S., He M., Sayed D., Vashistha H., Malhotra A., Sadoshima J., Vatner D. E., Vatner S. F., Abdellatif M., Downregulation of MiR-199a derepresses hypoxia-inducible factor-1 and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circulation Research 2009 104 7 879 886 2-s2.0-65249185780 10.1161/CIRCRESAHA.108.193102
16. Brown B. D., Venneri M. A., Zingale A., Sergi L. S., Naldini L., Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer. Nature Medicine 2006 12 5 585 591 2-s2.0-33646564701 10.1038/nm1398
17. Brown B. D., Gentner B., Cantore A., Colleoni S., Amendola M., Zingale A., Baccarini A., Lazzari G., Galli C., Naldini L., Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nature Biotechnology 2007 25 12 1457 1467 2-s2.0-36849060584 10.1038/nbt1372
18. Brown B. D., Naldini L., Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nature Reviews Genetics 2009 10 8 578 585 2-s2.0-67651087321 10.1038/nrg2628
19. Luo Y., Fan Y., Zhou B., Xu Z., Chen Y., Sun X., Generation of induced pluripotent stem cells from skin fibroblasts of a patient with olivopontocerebellar atrophy. The Tohoku Journal of Experimental Medicine 2012 226 2 151 159 10.1620/tjem.226.151
20. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S., Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007 131 5 861 872 2-s2.0-36248966518 10.1016/j.cell.2007.11.019
21. Tyler M. A., Ulasov I. V., Sonabend A. M., Nandi S., Han Y., Marler S., Roth J., Lesniak M. S., Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo. Gene Therapy 2009 16 2 262 278 2-s2.0-60449099546 10.1038/gt.2008.165
22. Shibata T., Giaccia A. J., Brown J. M., Development of a hypoxia-responsive vector for tumor-specific gene therapy. Gene Therapy 2000 7 6 493 498 2-s2.0-0034017489
23. Kaluz S., Kaluzova M., Stanbridge E. J., Rational design of minimal hypoxia-inducible enhancers. Biochemical and Biophysical Research Communications 2008 370 4 613 618 2-s2.0-43049157977 10.1016/j.bbrc.2008.03.147
24. Lee E. X., Lam D. H., Wu C., Yang J., Tham C. K., Ng W. H., Wang S., Glioma gene therapy using induced pluripotent stem cell derived neural stem cells. Molecular Pharmaceutics 2011 8 5 1515 1524 2-s2.0-80053517273 10.1021/mp200127u
25. Kim Y., Lin Q., Zelterman D., Yun Z., Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity. Cancer Research 2009 69 24 9271 9280 2-s2.0-73649094822 10.1158/0008-5472.CAN-09-1605
26. Kim Y., Lin Q., Glazer P. M., Yun Z., Hypoxic tumor microenvironment and cancer cell differentiation. Current Molecular Medicine 2009 9 4 425 434 2-s2.0-68349133231 10.2174/156652409788167113
27. Soeda A., Park M., Lee D., Mintz A., Androutsellis-Theotokis A., McKay R. D., Engh J., Iwama T., Kunisada T., Kassam A. B., Pollack I. F., Park D. M., Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1 Oncogene 2009 28 45 3949 3959 2-s2.0-70449687092 10.1038/onc.2009.252
28. Anderson K. M., Jajeh A., Guinan P., Rubenstein M., Are cancer stem cells concentrated in more alkaline hypoxic regions of tumors? Medical Hypotheses 2010 74 5 868 870 2-s2.0-77950949729 10.1016/j.mehy.2009.11.027
29. Wu C., Lin J., Hong M., Choudhury Y., Balani P., Leung D., Dang L. H., Zhao Y., Zeng J., Wang S., Combinatorial control of suicide gene expression by tissue-specific promoter and microrna regulation for cancer therapy. Molecular Therapy 2009 17 12 2058 2066 2-s2.0-73849105202 10.1038/mt.2009.225
30. Lee M., Hypoxia targeting gene expression for breast cancer gene therapy. Advanced Drug Delivery Reviews 2009 61 10 842 849 2-s2.0-67649210790 10.1016/j.addr.2009.04.017